Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cytosorbents Corp (CTSO)
NASDAQ:CTSO
Cytosorbents (CTSO) Stock Price & Analysis
436 Followers
CTSO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.03 - $4.59
Previous Close$1.65
Volume70.40K
Average Volume (3M)64.50K
Market Cap
$73.20M
Enterprise Value$78.16M
Total Cash (Recent Filing)$13.15M
Total Debt (Recent Filing)$18.11M
Price to Earnings (P/E)-2.7
Beta1.00
Next Earnings
Nov 07, 2023EPS Estimate
-$0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.60
Shares Outstanding44,362,386
10 Day Avg. Volume96,953
30 Day Avg. Volume64,495
Standard Deviation0.21
R-Squared0.05
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)3.04
Price to Sales (P/S)7.77
Price to Cash Flow (P/CF)-2.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.92
Enterprise Value/Gross Profit3.77
Enterprise Value/Ebitda-3.64
Forecast
1Y Price Target
$4.75Price Target Upside196.87% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Cytosorbents News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CTSO FAQ
What was Cytosorbents Corp’s price range in the past 12 months?
Cytosorbents Corp lowest stock price was $1.03 and its highest was $4.59 in the past 12 months.
What is Cytosorbents Corp’s market cap?
Currently, no data Available
When is Cytosorbents Corp’s upcoming earnings report date?
Cytosorbents Corp’s upcoming earnings report date is Nov 07, 2023 which is in 20 days.
How were Cytosorbents Corp’s earnings last quarter?
Cytosorbents Corp released its earnings results on Aug 01, 2023. The company reported -$0.14 earnings per share for the quarter, missing the consensus estimate of -$0.113 by -$0.027.
Is Cytosorbents Corp overvalued?
According to Wall Street analysts Cytosorbents Corp’s price is currently Undervalued.
Does Cytosorbents Corp pay dividends?
Cytosorbents Corp does not currently pay dividends.
What is Cytosorbents Corp’s EPS estimate?
Cytosorbents Corp’s EPS estimate is -$0.12.
How many shares outstanding does Cytosorbents Corp have?
Cytosorbents Corp has 44,362,385 shares outstanding.
What happened to Cytosorbents Corp’s price movement after its last earnings report?
Cytosorbents Corp reported an EPS of -$0.14 in its last earnings report, missing expectations of -$0.113. Following the earnings report the stock price went down -7.459%.
Which hedge fund is a major shareholder of Cytosorbents Corp?
Among the largest hedge funds holding Cytosorbents Corp’s share is Royce & Associates LLC. It holds Cytosorbents Corp’s shares valued at N/A.
---
Cytosorbents Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.75 (196.87% Upside)
$4.75 (196.87% Upside)
Hedge Fund Trend
Decreased
By 349.0K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-1.78%
12-Months-Change
Fundamentals
Return on Equity
-73.82%
Trailing 12-Months
Asset Growth
-26.35%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cytosorbents Corp
CytoSorbents Corp. engages in the research and development of blood purification technology for the reduction of deadly uncontrolled inflammation in hospitalized patients. Its product include CytoSorb, ContrastSorb, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.
---
Top 5 ETFs holding CTSO
Vanguard Total Stock Market ETF
$2.45M
Up to five ETFs with an Outperform Smart Score that hold CTSO. The ETFs are listed according to market value of CTSO within the ETF
---